Virtual Visits by Supportive Care Specialists to Cancer Patients at Home: A Randomized Controlled Pilot Noninferiority Trial of Video Telemedicine

Status: Active, not recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable

This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine (virtual medical visits using telecommunications technologies) is as effective as in-person supportive care visits in the clinic.

Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: Accepts Healthy Volunteers

• age 18 years or older

• solid tumor of any type

• completed an initial in-person clinic visit (i.e. an IR/NV or AFX visit) at Rockefeller Outpatient Pavilion with Dr. Saldivar, Dr. Martin, Supportive Care physicians, or Andrea Dolan, a Supportive Care nurse practitioner

• planned for Supportive Care Service follow-up visits, but none yet completed

• enrolled on the MyMSK secure online patient portal and have access to the portal off site of MSK campuses

• resident of New York or New Jersey or Connecticut (clinicians may not be licensed in other states, as would be required for televisits to patients there)

United States
New York
Memorial Sloan Kettering Cancer Center
New York
Time Frame
Start Date: October 24, 2019
Estimated Completion Date: October 2023
Target number of participants: 33
Active Comparator: In-person follow-up
Due to the COVID-19 pandemic, patients originally randomized to the in-person group received telemedicine visits. Thus, the researchers will expand our sample for these interviews to include patients who have completed at least 2 telemedicine follow-up visits whether they were originally randomized to the in-person group or the home telemedicine group.
Experimental: Home Telemedicine follow-up
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from

Similar Clinical Trials